OM
Outset Medical, Inc. Healthcare - Medical Devices Investor Relations →
Outset Medical, Inc. (OM) closed at $3.36 as of 2026-03-20, trading 97.2% below its 200-week moving average of $120.93. This places OM in the extreme value zone. The stock moved further from the line this week, up from -97.3% last week. The 14-week RSI sits at 42, indicating neutral momentum.
Trading activity has gone quiet — just 0.3x of its usual 14-week average. But the buying that is happening outweighs the selling (3.36 buyers-vs-sellers ratio). When volume dries up but buyers are still showing up more than sellers, it can mean the worst of the selling is over and the stock is quietly building a floor.
Over the past 239 weeks of data, OM has crossed below its 200-week moving average 3 times. On average, these episodes lasted 77 weeks. The average one-year return after crossing below was -63.5%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $62 million, OM is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -106.2%. The stock trades at 0.5x book value.
Share count has increased 462.3% over three years, indicating dilution.
Over the past 4.7 years, a hypothetical investment of $100 in OM would have grown to $0, compared to $153 for the S&P 500. OM has returned -68.6% annualized vs 9.6% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: OM vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After OM Crosses Below the Line?
Across 3 historical episodes, buying OM when it crossed below its 200-week moving average produced an average return of -61.3% after 12 months (median -66.0%), compared to -12.0% for the S&P 500 over the same periods. After 24 months, the average return was -79.0% vs +3.0% for the index.
Each line shows $100 invested at the moment OM crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
OM has crossed below its 200-week MA 3 times with an average 1-year return of +-63.5% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Aug 2021 | Sep 2021 | 2 | 8.2% | -59.4% | -99.5% |
| Sep 2021 | Oct 2021 | 3 | 4.0% | -67.7% | -99.5% |
| Nov 2021 | Ongoing | 227+ | 98.2% | Ongoing | -99.5% |
| Average | 77 | — | +-63.5% | — |
Frequently Asked Questions
Is OM below its 200-week moving average?
Yes. As of 2026-03-20, Outset Medical, Inc. (OM) is trading 97.2% below its 200-week moving average of $120.93. The current price is $3.36.
What is OM's 200-week moving average price?
Outset Medical, Inc.'s 200-week moving average is $120.93 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when OM drops below its 200-week moving average?
OM has crossed below its 200-week moving average 3 times in our data. The average one-year return after these crossings was -63.5%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 77 weeks on average.
Is OM a good value right now?
Here's what our data says about OM as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 42. Free cash flow is currently negative. Return on equity is -106.2%. Price-to-book is 0.5x. This is not a buy or sell recommendation — always do your own research.
How does OM compare to the S&P 500?
Over the past 4.7 years, $100 invested in OM would have grown to $0, compared to $153 for the S&P 500. That's -68.6% annualized vs 9.6% for the index. OM has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20